Tuberous sclerosis complex: A multisystem disorder.
Journal
JAAPA : official journal of the American Academy of Physician Assistants
ISSN: 1547-1896
Titre abrégé: JAAPA
Pays: United States
ID NLM: 9513102
Informations de publication
Date de publication:
01 03 2021
01 03 2021
Historique:
pubmed:
3
2
2021
medline:
25
11
2021
entrez:
2
2
2021
Statut:
ppublish
Résumé
Tuberous sclerosis complex (TSC) is a genetic disorder that affects multiple organ systems but often goes unrecognized, and a delay in diagnosis can lead to multiple complications. Healthcare professionals should be educated on the many signs and symptoms associated with the disorder, know how to treat them symptomatically, and recommend routine screening to assess for complications. Correctly identifying, diagnosing, and treating TSC can give patients a better quality of life and prevent further complications associated with the disorder.
Identifiants
pubmed: 33528170
doi: 10.1097/01.JAA.0000733220.26720.62
pii: 01720610-202103000-00003
doi:
Types de publication
Journal Article
Langues
eng
Pagination
28-33Informations de copyright
Copyright © 2021 American Academy of Physician Assistants.
Références
Morrison PJ. Tuberous sclerosis: epidemiology, genetics and progress towards treatment. Neuroepidemiology . 2009;33(4):342–343.
Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet . 2008;372(9639):657–668.
Portocarrero LKL, Quental KN, Samorano LP, et al. Tuberous sclerosis complex: review based on new diagnostic criteria. An Bras Dermatol . 2018;93(3):323–331.
Jameson JL, Fauci AS, Kasper DL, et al. Harrison's Principles of Internal Medicine . 20th ed. New York, NY: McGraw-Hill Education; 2018.
National Organization for Rare Disorders. Tuberous sclerosis. https://rarediseases.org/rare-diseases/tuberous-sclerosis . Accessed November 6, 2020.
Tuberous Sclerosis Alliance. What is TSC? www.tsalliance.org/about-tsc/what-is-tsc . Accessed November 6, 2020.
Tuberous Sclerosis Alliance. Epilepsy and seizure disorders. www.tsalliance.org/about-tsc/signs-and-symptoms-of-tsc/brain-and-neurological-function/epilepsy-and-seizure-disorders . Accessed November 6, 2020.
Boronat S, Caruso P, Auladell M, et al. Arachnoid cysts in tuberous sclerosis complex. Brain Dev . 2014;36(9):801–806.
Northrup H, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol . 2013;49(4):243–254.
Rakowski SK, Winterkorn EB, Paul E, et al. Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int . 2006;70(10):1777–1782.
Kingswood JC, Bissler JJ, Budde K, et al. Review of the tuberous sclerosis renal guidelines from the 2012 consensus conference: current data and future study. Nephron . 2016;134(2):51–58.
Iwata W, Unoki-Kubota H, Kato H, et al. Podocyte-specific deletion of tubular sclerosis complex 2 promotes focal segmental glomerulosclerosis and progressive renal failure. PLoS One . 2020;15(3):e0229397.
Caban C, Khan N, Hasbani DM, Crino PB. Genetics of tuberous sclerosis complex: implications for clinical practice. Appl Clin Genet . 2016;10:1–8.
Krueger DA, Northrup H; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol . 2013;49(4):255–265.
Tuberous Sclerosis Alliance. Treatment guidelines. www.tsalliance.org/individuals-families/treatment-guidelines . Accessed November 6, 2020.
US Food and Drug Administration. Center for Drug Evaluation and Research. FDA approves everolimus for tuberous sclerosis complex-associated. www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-everolimus-tuberous-sclerosis-complex-associated-partial-onset-seizures . Accessed November 6, 2020.
Franz DN. Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex. Biologics . 2013;7:211–221.